These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 19106019)

  • 41. [Correlation between Gleason score on prostate biopsies diagnostic of adenocarcinoma and radical prostatectomy specimens].
    Montesino Semper M; Jiménez Aristu J; Repáraz Romero B; Ruiz Ramo M; Villanueva Pérez I; Hualde Alfaro A; Pinós Paul M; De Pablo Cárdenas A
    Arch Esp Urol; 2004 Jun; 57(5):519-23. PubMed ID: 15382569
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Prostate saturation biopsy in the reevaluation of microfocal prostate cancer.
    Boccon-Gibod LM; de Longchamps NB; Toublanc M; Boccon-Gibod LA; Ravery V
    J Urol; 2006 Sep; 176(3):961-3; discussion 963-4. PubMed ID: 16890668
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prediction of extraprostatic extension in men with biopsy Gleason score of 8 or greater.
    Nakanishi H; Troncoso P; Babaian RJ
    J Urol; 2008 Dec; 180(6):2441-5; discussion 2445-6. PubMed ID: 18930495
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Usefulness of the 2005 International Society of Urologic Pathology Gleason grading system in prostate biopsy and radical prostatectomy specimens.
    Uemura H; Hoshino K; Sasaki T; Miyoshi Y; Ishiguro H; Inayama Y; Kubota Y
    BJU Int; 2009 May; 103(9):1190-4. PubMed ID: 19076142
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Is PCA3 score useful in preoperative staging of a single microfocus of prostate cancer diagnosed at saturation biopsy?
    Pepe P; Fraggetta F; Galia A; Aragona F
    Urol Int; 2012; 89(2):143-7. PubMed ID: 22868485
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Correlation between the Gleason scores of needle biopsies and radical prostatectomy specimens.
    Shen BY; Tsui KH; Chang PL; Chuang CK; Hsieh ML; Huang ST; Wang TM; Lee SH; Huang HC; Huang SC
    Chang Gung Med J; 2003 Dec; 26(12):919-24. PubMed ID: 15008327
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparing the Gleason prostate biopsy and Gleason prostatectomy grading system: the Lahey Clinic Medical Center experience and an international meta-analysis.
    Cohen MS; Hanley RS; Kurteva T; Ruthazer R; Silverman ML; Sorcini A; Hamawy K; Roth RA; Tuerk I; Libertino JA
    Eur Urol; 2008 Aug; 54(2):371-81. PubMed ID: 18395322
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Accuracy of MRI-Targeted in-Bore Prostate Biopsy According to the Gleason Score with Postprostatectomy Histopathologic Control--a Targeted Biopsy-Only Strategy with Limited Number of Cores.
    Garmer M; Busch M; Mateiescu S; Fahlbusch DE; Wagener B; Grönemeyer DH
    Acad Radiol; 2015 Nov; 22(11):1409-18. PubMed ID: 26343218
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Validation of Partin tables and development of a preoperative nomogram for Japanese patients with clinically localized prostate cancer using 2005 International Society of Urological Pathology consensus on Gleason grading: data from the Clinicopathological Research Group for Localized Prostate Cancer.
    Naito S; Kuroiwa K; Kinukawa N; Goto K; Koga H; Ogawa O; Murai M; Shiraishi T;
    J Urol; 2008 Sep; 180(3):904-9; discussion 909-10. PubMed ID: 18635221
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Prostate cancer: Gleason scores correlation between biopsies and surgical gross specimen].
    Peko JF; Odzebe AW; Nsonde-Malanda J; Bambara AT; Ngolet A
    Prog Urol; 2011 Oct; 21(9):615-8. PubMed ID: 21943657
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer.
    Burdick MJ; Reddy CA; Ulchaker J; Angermeier K; Altman A; Chehade N; Mahadevan A; Kupelian PA; Klein EA; Ciezki JP
    Int J Radiat Oncol Biol Phys; 2009 Apr; 73(5):1439-45. PubMed ID: 18963536
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A pathological reassessment of organ-confined, Gleason score 6 prostatic adenocarcinomas that progress after radical prostatectomy.
    Miyamoto H; Hernandez DJ; Epstein JI
    Hum Pathol; 2009 Dec; 40(12):1693-8. PubMed ID: 19683331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is the biopsy Gleason score important in predicting outcomes for patients after radical prostatectomy once the pathological Gleason score is known?
    Vira MA; Guzzo T; Heitjan DF; Tomaszewski JE; D'Amico A; Wein AJ; Malkowicz SB
    BJU Int; 2008 May; 101(10):1232-6. PubMed ID: 18419697
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prediction of radial distance of extraprostatic extension from pretherapy factors.
    Schwartz DJ; Sengupta S; Hillman DW; Sargent DJ; Cheville JC; Wilson TM; Mynderse LA; Choo R; Davis BJ
    Int J Radiat Oncol Biol Phys; 2007 Oct; 69(2):411-8. PubMed ID: 17869661
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between prostate needle biopsy and radical prostatectomy Gleason gradings of 111 cases with prostatic adenocarcinoma.
    Tavangar SM; Razi A; Mashayekhi R
    Urol J; 2004; 1(4):246-9. PubMed ID: 17914699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A clinicopathologic study of preoperative and postoperative findings with minute Gleason 3+3=6 cancer at radical prostatectomy.
    Osunkoya AO; Carter HB; Epstein JI
    Urology; 2008 Sep; 72(3):638-40. PubMed ID: 18400278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Analysis of anatomopathological results of radical prostatectomy specimen of patients who answer to criteria for active surveillance of prostate cancer].
    Azancot V; Peyromaure M; Xylinas E; Descazeaud A; Cornud F; Vieillefond A; Saighi D; Amsellem-Ouazana D; Debré B; Zerbib M
    Prog Urol; 2009 Oct; 19(9):619-23. PubMed ID: 19800552
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risk of prostate cancer after diagnosis of atypical glands suspicious for carcinoma on saturation and traditional biopsies.
    Abouassaly R; Tan N; Moussa A; Jones JS
    J Urol; 2008 Sep; 180(3):911-4; discussion 914. PubMed ID: 18635220
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gleason scoring: a comparison of classical and modified (international society of urological pathology) criteria using nadir PSA as a clinical end point.
    Delahunt B; Lamb DS; Srigley JR; Murray JD; Wilcox C; Samaratunga H; Atkinson C; Spry NA; Joseph D; Denham JW
    Pathology; 2010 Jun; 42(4):339-43. PubMed ID: 20438406
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Upgrading the Gleason score in extended prostate biopsy: implications for treatment choice.
    Moreira Leite KR; Camara-Lopes LH; Dall'Oglio MF; Cury J; Antunes AA; Sañudo A; Srougi M
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):353-6. PubMed ID: 18774658
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.